visor2™ leaflet: Psychiatric disorders
1 / 2ページ

{{requestButtons}}

カタログの抜粋

visor2™ leaflet: Psychiatric disorders - 1

Treatment of Psychiatric Disorders The visor2 system is not available for sale in all countries, please refer to the associated visor2 specification documents or contact you local representative for details. https://www.ant-neuro.com/contact-us

カタログの1ページ目を開く
visor2™ leaflet: Psychiatric disorders - 2

Treatment of Psychiatric Disorders One-third of adults with Major Depressive Disorder (MDD) have experienced persistent symptoms which do not respond to pharmacological treatment. Navigated repeated TMS (rTMS) has been approved by the U.S. FDA and several regulatory agencies around the world as a non-invasive treatment for Major Depressive Disorder. rTMS has been proven beneficial for treatment-resistant MDD patients who had not previously responded to any antidepressant medication. More recently, long-term gains have been observed in MDD patients receiving rTMS treatment followed by...

カタログの2ページ目を開く

ANT Neuroのすべてのカタログと技術パンフレット

  1. eego™24 brochure

    3 ページ

  2. asa™ brochure

    3 ページ

  3. xensor™ brochure

    3 ページ

  4. eego™rt brochure

    3 ページ

  5. eego™8 brochure

    3 ページ

  6. nëo™ brochure

    3 ページ

  7. visor2™ brochure

    3 ページ